DEA submits final telemedicine special registration rule for review - Medical Buyer
DEA has submitted its final telemedicine special registration rule for review, which will establish a new pathway for prescribing controlled substances via telemedicine without an in-person visit.
Aforeworn detected this change in the Telehealth Cross-State Licensing space on September 2, 2026 and published this briefing so affected operators are forewarned rather than caught off guard. It is rated Medium urgency. Telehealth platforms, virtual specialty clinics, behavioral-health providers, and e-prescribers that prescribe controlled substances via telemedicine. should confirm how it applies to their specific situation before acting. There is a time constraint attached: Not specified in the source; monitor for publication and effective date.. Acting after that point can mean penalties, a lapsed licence, or lost eligibility — exactly the kind of surprise Aforeworn exists to prevent. Aforeworn monitors Telehealth Cross-State Licensing continuously and turns every detected change into a plain-English briefing like this one, so you always know first. Forewarned is forearmed.
What changed
The DEA has submitted the final rule for special registration, which will likely create a new registration process for telemedicine prescribing of controlled substances.
Who it affects
Telehealth platforms, virtual specialty clinics, behavioral-health providers, and e-prescribers that prescribe controlled substances via telemedicine.
What you must do
Monitor the Federal Register for the final rule's publication and prepare to comply with new registration requirements once effective.
Deadline
Not specified in the source; monitor for publication and effective date.
Never miss a change like this again
Aforeworn watches Telehealth Cross-State Licensing around the clock and alerts you the moment a rule moves — with a plain-English brief on what to do.
Start your free trialRelated changes in Telehealth Cross-State Licensing
- Biden admin seeks to limit telehealth prescriptions for some drugs - axios.com
- CMS Clarifies Medicare Recognition of Interstate Licensure Compacts - techtarget.com
- Folx Health, Plume Prepare for Tighter Regulation of Online Testosterone - businessinsider.com
- Virginians weigh in on new telehealth proposal for controlled substances - virginiamercury.com
- Texas wants to ban in-home ketamine and add more physician oversight during treatment - texastribune.org